Tobias F. Rinke de Wit

Author

Also Known As

Rinke De Wit, Tobias F., Rinke de Wit, Tobias F., T F RINKE DE WIT, T F Rinke de Wit, T. F. R. d. Wit, T. F. Rinke De Wit, T. F. Rinke de Wit, T. Wit, T.F. Rinke de Wit, TOBIAS F. RINKE DE WIT

253

Publications

8.2K

Citations

H-Index

127

Concepts

All Affiliations

University of Amsterdam Amsterdam Institute for Global Health and Development Amsterdam UMC Location University of Amsterdam PharmAccess Group Joint Clinical Research Centre

About

Tobias F. Rinke de Wit is an author at University of Amsterdam specializing in medicine, hiv, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	36	2.1K
2	Public Health	21	29	1.4K
3	Health Sciences	2	2	71
4	Nursing	2	2	37
5	Engineering	1	1	17

Tobias F. Rinke de Wit

123

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Hypertension in Sub-Saharan Africa: Cross-Sectional Surveys in Four Rural and Urban Communities Marleen Elisabeth Hendriks, Ferdinand W N M Wit, Marijke Roos, PLoS ONE	2012	414
Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection Mette D. Hazenberg, Sigrid A. Otto, J. W. T. Cohen Stuart, Nature Medicine Cell DivisionHuman RetrovirusT-regulatory CellImmunologyThymic Dysfunction	2000	395
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study Raph L Hamers, Carole L. Wallis, Cissy Kityo, The Lancet Infectious Diseases EpidemiologyAntiretroviral TherapyHiv/aids CounsellingTreatment And PreventionHuman Retrovirus	2011	289
Immunohematological Reference Ranges for Adult Ethiopians Aster Tsegaye, Tsehaynesh Messele, Tesfaye Tilahun, Clinical and Diagnostic Laboratory Immunology	1999	196
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study Raph L Hamers, Rob Schuurman, Kim Sigaloff, The Lancet Infectious Diseases Drug-resistance OutcomesHiv/aids CounsellingTreatment And PreventionHuman RetrovirusGlobal Health	2011	194
Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa Kim Sigaloff, Raph L Hamers, Carole L. Wallis, JAIDS Journal of Acquired Immune Deficiency Syndromes	2011	184
HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS Almaz Abebe, Dereje Bayissa Demissie, Jaap Goudsmit, AIDS	1999	166
Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing, Clinical Infectious Diseases	2012	160
Association between health worker motivation and healthcare quality efforts in Ghana Robert Kaba Alhassan, Nicole Spieker, Paul Van Ostenberg, Human Resources for Health	2013	140
Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts Tsehaynesh Messele, Mohammed Baba Abdulkadir, Arnaud Fontanet, Clinical & Experimental Immunology	1999	117

Page 1